State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies
Introduction: Idiosyncratic drug-induced neutropenia and agranulocytosis is seldom discussed in the literature, especially for new drugs such as biotherapies outside the context of oncology. In the present paper, we report and discuss the clinical data and management of this relatively rare disorder...
Main Authors: | Emmanuel Andrès, Noel Lorenzo Villalba, Abrar-Ahmad Zulfiqar, Khalid Serraj, Rachel Mourot-Cottet, Jacques-Eric Gottenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/9/1351 |
Similar Items
-
Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea
by: Hee Kyung Kim, et al.
Published: (2015-12-01) -
Idiosyncratic Drug-Induced Neutropenia and Agranulocytosis in Elderly Patients
by: Noel Lorenzo-Villalba, et al.
Published: (2020-06-01) -
Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous
by: Bernd Rattay, et al.
Published: (2021-08-01) -
Biotherapies in Uveitis
by: Mathilde Leclercq, et al.
Published: (2020-11-01) -
Carbimazole induced agranulocytosis with life-threatening complications, tremendous response with granulocyte-colony stimulating factor
by: Seema Mahant, et al.
Published: (2016-01-01)